Changes in the Tricuspid Valve Complex Induced by Mitral Valve Annuloplasty

Sponsor
Universitaire Ziekenhuizen Leuven (Other)
Overall Status
Terminated
CT.gov ID
NCT02357862
Collaborator
(none)
22
13

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the impact of isolated mitral valve annuloplasty on the geometry and the function of the tricuspid valve complex.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Mitral Valve Annuloplasty

Detailed Description

The proposed pathogenesis of functional tricuspid regurgitation (TR) in mitral valve disease seems incomplete. Because both atrioventricular valves are closely connected to each other by means of the cardiac fibrous skeleton, the geometry of the tricuspid valve is likely to be distorted after ring-annuloplasty of the mitral valve. This could lead to the development of functional TR, or to an increase in TR severity. To test this hypothesis, a prospective study will be started in patients undergoing isolated mitral valve annuloplasty.

Study Design

Study Type:
Observational
Actual Enrollment :
22 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Impact of Mitral Valve Annuloplasty on the Tricuspid Valve Complex
Actual Study Start Date :
Jan 1, 2015
Actual Primary Completion Date :
Feb 1, 2016
Actual Study Completion Date :
Feb 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Mitral Valve Annuloplasty

All eligible patients

Procedure: Mitral Valve Annuloplasty
Mitral valve annuloplasty by a rigid mitral ring, a semi-rigid ring, or a fully flexible band, at the surgeon's discretion

Outcome Measures

Primary Outcome Measures

  1. Postoperative geometric changes in tricuspid valve annulus (TA) [day 0]

    Measurement of changes in 3D descriptors of the TA (e.g. changes from baseline in the TA area of the best-fit plane in cm^2, and changes from baseline in the height of each TA point to the TA best-fit plane in mm)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • all patients 18 years of age or older undergoing minimally invasive, isolated mitral valve annuloplasty
Exclusion Criteria:
  • concomitant tricuspid valve surgery

  • atrial fibrillation at the moment of surgery

  • poor echocardiographic windows

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Universitaire Ziekenhuizen Leuven

Investigators

  • Principal Investigator: Werner Budts, M.D., PhD, KU Leuven - University of Leuven, Department of Cardiovascular Sciences, Division of Cardiology; University Hospitals Leuven, Department of Cardiology

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Universitaire Ziekenhuizen Leuven
ClinicalTrials.gov Identifier:
NCT02357862
Other Study ID Numbers:
  • MVR_TV
First Posted:
Feb 6, 2015
Last Update Posted:
May 8, 2018
Last Verified:
Jul 1, 2015
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Universitaire Ziekenhuizen Leuven
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 8, 2018